LPPR4, or Lipid Phosphate Phosphatase-Related Protein Type 4, is a gene encoding a member of the lipid phosphate phosphatase (LPP) family. This family is involved in regulating lipid signaling by dephosphorylating lipid phosphate substrates, such as phosphatidic acid (PA), lysophosphatidic acid (LPA), and sphingosine-1-phosphate (S1P). These lipids act as signaling molecules, playing vital roles in various cellular processes.LPPR4, specifically, is implicated in the regulation of lipid-mediated signaling pathways. By modulating the levels of lipid phosphate substrates, it influences signal transduction processes that are crucial for cell growth, survival, migration, and differentiation. This regulatory mechanism is significant in both normal physiological processes and pathological conditions.
The expression of LPPR4 is noted in various tissues, suggesting a broad role in different physiological contexts. Its function in the nervous system has garnered particular interest. LPPR4 is thought to be involved in neural development and function, influencing processes such as neurite outgrowth and synaptic function. These roles are critical for proper brain development and neural network formation. Moreover, the dysregulation of lipid signaling pathways in which LPPR4 participates can contribute to the development of diseases. For instance, aberrant LPA and S1P signaling has been linked to cancer, cardiovascular diseases, and neurological disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
As a signaling molecule metabolized by lipid phosphate phosphatases, LPA can indirectly affect LPPR4 function. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
A sphingosine-1-phosphate receptor modulator, FTY720 can influence lipid signaling pathways, potentially impacting LPPR4. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Involved in lipid signaling, S1P levels can indirectly affect LPPR4's role in phospholipid metabolism. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
A key component in sphingolipid metabolism, ceramide can influence lipid signaling pathways, potentially impacting LPPR4. | ||||||
Miltefosine | 58066-85-6 | sc-203135 | 50 mg | $81.00 | 8 | |
An alkylphosphocholine drug affecting phospholipid metabolism, potentially influencing LPPR4 activity. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $150.00 | 8 | |
An inhibitor of serine palmitoyltransferase, affecting sphingolipid synthesis, and potentially influencing LPPR4 activity. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A beta-blocker known to affect phospholipid metabolism, potentially influencing LPPR4 function. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
A statin that affects lipid metabolism, potentially impacting pathways related to LPPR4. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist, Isoproterenol can affect lipid signaling pathways, indirectly influencing LPPR4. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Known to affect phosphoinositide metabolism, potentially impacting LPPR4 activity. | ||||||